Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Covista Inc.

Consumer Defensive US CVSA

119.07USD
1.73(1.47%)

Last update at 2026-06-18T20:08:00Z

Day Range

115.50119.42
LowHigh

52 Week Range

86.97156.26
LowHigh

Fundamentals

  • Previous Close 117.34
  • Market Cap4313.65M
  • Volume483522
  • P/E Ratio17.49
  • Dividend Yield-%
  • EBITDA428.91M
  • Revenue TTM1888.83M
  • Revenue Per Share TTM52.10
  • Gross Profit TTM 1083.84M
  • Diluted EPS TTM6.79

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax 298.51M 163.94M 112.03M -51.49400M 83.42M
Minority interest - - 0.00000M 0.18M 1.79M
Net income 232.68M 136.78M 96.93M -162.49200M 76.91M
Selling general administrative 423.71M 386.56M 356.61M 375.79M 219.78M
Selling and marketing expenses 247.40M 227.90M 219.40M 190.70M 72.70M
Gross profit 1016.86M 886.10M 774.10M 651.93M 460.02M
Reconciled depreciation 84.47M 107.96M 151.28M 186.60M 99.05M
Ebit 342.85M 271.64M 226.33M 155.57M 156.51M
Ebitda 427.31M 346.96M 377.42M 342.17M 241.05M
Depreciation and amortization 84.47M 75.32M 151.09M 186.60M 84.54M
Non operating income net other - - 6.96M -125.52800M -34.63300M
Operating income 341.54M 217.05M 226.33M 155.57M 156.51M
Other operating expenses 1446.75M 1367.60M 1224.49M 1226.27M 750.39M
Interest expense 52.32M 63.66M 63.17M 129.35M 42.84M
Tax provision 65.84M 26.22M 10.28M -15.23700M 25.25M
Interest income 8.22M 9.18M 10.65M 3.82M 4.09M
Net interest income -44.10200M -63.65900M -63.17100M -123.07500M -37.27100M
Extraordinary items - - - - -
Non recurring - - 48.16M 78.83M 41.40M
Other items - - - - -
Income tax expense 65.84M 26.22M 10.28M -15.53900M 13.09M
Total revenue 1788.29M 1584.65M 1450.83M 1381.84M 906.90M
Total operating expenses 675.32M 669.05M 547.77M 496.36M 303.50M
Cost of revenue 771.43M 698.55M 676.73M 729.91M 446.88M
Total other income expense net -43.02800M -53.11700M -114.29600M -207.06600M -73.09500M
Discontinued operations - - -8.39400M 347.53M -25.12700M
Net income from continuing ops 232.68M 137.71M 101.75M -29.82700M 101.60M
Net income applicable to common shares - - 93.36M 317.70M 76.91M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 2752.35M 2741.42M 2810.54M 3030.24M 3084.84M
Intangible assets 765.47M 776.69M 812.34M 873.58M 137.50M
Earning assets - - - - -
Other current assets 70.40M 71.95M 105.35M 128.50M 995.53M
Total liab 1318.73M 1372.28M 1353.20M 1538.85M 1781.98M
Total stockholder equity 1433.62M 1369.13M 1457.34M 1491.39M 1301.07M
Deferred long term liab - - 26.07M 25.55M 1.50M
Other current liab 367.75M 353.60M 311.72M 315.73M 309.39M
Common stock 0.84M 0.83M 0.82M 0.82M 0.81M
Capital stock 0.84M 0.83M 0.82M 0.82M 0.81M
Retained earnings 2777.57M 2540.51M 2403.75M 2310.40M 2005.11M
Other liab - - 63.48M 90.63M 106.60M
Good will 961.26M 961.26M 961.26M 961.26M 310.21M
Other assets - - 125.20M 170.38M 110.08M
Cash 199.60M 219.31M 272.19M 346.97M 476.38M
Cash and equivalents - - - - -
Total current liabilities 507.93M 487.66M 431.20M 423.65M 408.81M
Current deferred revenue 214.09M 185.27M 153.87M 149.81M 149.81M
Net debt 574.40M 628.55M 624.00M 719.76M 824.29M
Short term debt 35.16M 31.43M 37.67M 50.78M 56.99M
Short long term debt - - - - 3.00M
Short long term debt total 774.00M 847.85M 896.19M 1066.73M 1300.67M
Other stockholder equity -1342.56100M -1169.97900M -945.00900M -817.60100M -697.48100M
Property plant equipment - - 258.52M 289.93M 466.18M
Total current assets 416.19M 418.08M 480.30M 557.10M 1514.95M
Long term investments - - - - -
Net tangible assets - - -316.26400M -329.77200M 338.45M
Short term investments 12.80M 13.20M 12.50M 17.80M 20.60M
Net receivables 146.19M 126.83M 102.75M 81.64M 43.04M
Long term debt 552.67M 648.71M 695.08M 838.91M 1067.71M
Inventory - 0.00000M 1.39M - -
Accounts payable 105.02M 102.63M 81.81M 57.14M 42.42M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - 1.79M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -2.22700M -2.22700M -2.22700M -2.22700M -7.36500M
Additional paid in capital - - - - -
Common stock total equity - - 0.82M 0.82M 0.81M
Preferred stock total equity - - - - -
Retained earnings total equity - - 2403.75M 2322.81M 2005.11M
Treasury stock - - - - -1217.30700M
Accumulated amortization - - - - -
Non currrent assets other 162.10M 160.10M 137.32M 170.38M 671.12M
Deferred long term asset charges - - - - -
Non current assets total 2336.16M 2323.33M 2330.24M 2473.14M 1569.89M
Capital lease obligations 221.33M 199.14M 201.11M 227.83M 223.18M
Long term debt total - - 695.08M 838.91M 1067.71M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments -41.92100M -47.85000M 52.93M 10.00M -8.02400M
Change to liabilities - - 12.03M 19.78M 17.64M
Total cashflows from investing activities -41.92100M -47.85000M 23.74M -551.80400M -56.68800M
Net borrowings -100.00000M -50.00000M -164.02300M -309.26600M 797.00M
Total cash from financing activities -316.01600M -301.79800M -288.51500M -424.47600M 676.47M
Change to operating activities - - -82.85100M -105.70500M -38.37500M
Net income 237.06M 136.78M 93.36M 310.99M 70.03M
Change in cash -20.03800M -53.87300M -72.86200M -965.67900M 812.51M
Begin period cash flow 221.20M 275.07M 347.94M 1313.62M 501.11M
End period cash flow 201.16M 221.20M 275.07M 347.94M 1313.62M
Total cash from operating activities 337.90M 295.77M 191.91M 10.60M 192.20M
Issuance of capital stock - - - - -
Depreciation 90.45M 113.62M 160.21M 229.25M 87.20M
Other cashflows from investing activities 8.41M 1.04M 49.75M 967.30M -16.80700M
Dividends paid - - 3.23M 9.41M 1.72M
Change to inventory - - -65.30600M - -22.62900M
Change to account receivables -80.82000M -76.35500M -56.30900M -41.39100M 15.44M
Sale purchase of stock -227.32500M -269.69700M -127.72500M -122.83400M -104.20600M
Other cashflows from financing activities 11.31M 17.90M -9.92900M -71.92900M -16.32800M
Change to netincome - - -3.26300M -133.40600M 21.49M
Capital expenditures 50.33M 48.89M 26.01M 31.05M 39.88M
Change receivables - - -37.61400M -29.88100M 13.26M
Cash flows other operating - - 119.81M -30.56900M 82.58M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - -72.86200M -965.67900M 811.98M
Change in working capital -148.98900M -111.86500M -134.33800M -137.83200M -23.57200M
Stock based compensation 41.59M 25.95M 14.30M 22.61M 12.82M
Other non cash items 117.78M 131.29M 58.38M -414.41900M 45.72M
Free cash flow 287.57M 246.88M 165.90M -20.45300M 152.32M

Peer Comparison

Sector: Consumer Defensive Industry: Education & Training Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CVSA
Covista Inc.		 1.73 1.47% 119.07 17.49 13.50 2.28 2.97 2.53 10.55
EDU
New Oriental Education & Technology		 -0.73 1.60% 45.02 23.48 13.93 1.83 2.40 1.01 8.63
TAL
TAL Education Group		 - -% 9.19 - 56.50 6.54 2.16 4.19 -40.7835
GHC
Graham Holdings Co		 19.23 1.71% 1144.66 17.20 20.12 1.01 1.04 1.01 6.72
LOPE
Grand Canyon Education Inc		 -0.87 0.61% 141.59 20.34 17.09 4.08 5.46 3.93 12.95

Reports Covered

Stock Research & News

View All

Profile

Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company offers degree and non-degree programs, including bachelor's, master's, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. It also operates Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as Adtalem Global Education Inc. and changed its name to Covista Inc. in February 2026. Covista Inc. was incorporated in 1987 and is headquartered in Chicago, Illinois.

Covista Inc.

233 South Wacker Drive, Chicago, IL, United States, 60606

Key Executives

Name Title Year Born
Mr. Stephen W. Beard J.D. CEO & Chairman 1971
Mr. Robert J. Phelan CPA Senior VP & CFO 1966
Mr. Douglas G. Beck J.D. Senior VP of Institutional Support Services, General Counsel & Corporate Secretary 1967
Mr. Michael Betz Chief Growth & Innovation Officer and President of Walden University 1974
Mr. Scott Day Liles President of Adtalem Medical & Veterinary 1967
Mr. Manjunath Gangadharan VP & Chief Accounting Officer 1984
Mr. Jeremy Cohen Vice President of Investor Relations NA
Ms. Sara Hill Senior VP & Chief Human Resources Officer 1970
Ms. Megan Noel Senior VP & Chief Corporate Affairs Officer 1986
Dr. Karen Sue Cox President of Chamberlain University 1961

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions